Tao Wang

5PUBLICATIONS
2CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2024
Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS.

Zhiqiang Song, Yang Wang, Dongliang Zhang

|Mar 15, 2024
In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies.

Zhiqiang Song, Ping Liu, Dongliang Zhang

|Nov 06, 2023
CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients.

Tao Wang, Ping Liu, Lili Xu

|Feb 10, 2022
Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study.

Tao Wang, Lili Xu, Lei Gao

|Aug 06, 2020
Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma.

Tao Wang, Lei Gao, Yujie Wang

Pageof 1

Frequent Collaborators

2 joint publications

Jianmin Yang

1 joint publications

Yang Wang